These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 18441679

  • 21. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
    Karapolat H, Eyigor S, Atasever A, Zoghi M, Nalbantgil S, Durmaz B.
    Chin Med J (Engl); 2008 Apr 05; 121(7):592-6. PubMed ID: 18466677
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
    Volkova LI, Budkova AA, Filonova NN, Khristoliubova EI, Kutuzova EB, Koroleva NV, Radzivil TT, Aminova ZR, Chuchalin AG.
    Ter Arkh; 2004 Apr 05; 76(8):51-6. PubMed ID: 15471398
    [Abstract] [Full Text] [Related]

  • 23. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N, Tertemiz KC, Sevinç C.
    Tuberk Toraks; 2008 Apr 05; 56(4):382-9. PubMed ID: 19123073
    [Abstract] [Full Text] [Related]

  • 24. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease.
    Umehara M, Yamaguchi A, Itakura S, Suenaga M, Sakaki Y, Nakashiki K, Miyata M, Tei C.
    J Cardiol; 2008 Apr 05; 51(2):106-13. PubMed ID: 18522783
    [Abstract] [Full Text] [Related]

  • 25. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec 05; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 26. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis].
    Хайменова ГС, Шилкина ЛН, Бабанина МЮ, Волченко ГВ, Ткаченко МВ, Ждан ВН.
    Wiad Lek; 2016 Dec 05; 69(2 Pt 2):214-8. PubMed ID: 27487536
    [Abstract] [Full Text] [Related]

  • 27. Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease.
    Shmelev EI, Kunicina YL.
    Clin Drug Investig; 2006 Dec 05; 26(3):151-9. PubMed ID: 17163246
    [Abstract] [Full Text] [Related]

  • 28. Quality of life: concept and definition.
    Kaplan RM, Ries AL.
    COPD; 2007 Sep 05; 4(3):263-71. PubMed ID: 17729071
    [Abstract] [Full Text] [Related]

  • 29. [Quality of life in COPD].
    Atasever A, Erdinç E.
    Tuberk Toraks; 2003 Sep 05; 51(4):446-55. PubMed ID: 15143396
    [Abstract] [Full Text] [Related]

  • 30. [Patient-reported parameters in chronic obstructive pulmonary disease].
    Moya V, Nieto D, Marín JM.
    Arch Bronconeumol; 2010 Sep 05; 46 Suppl 8():15-9. PubMed ID: 21334551
    [Abstract] [Full Text] [Related]

  • 31. Cognitive function and its effects on the quality of life status in the patients with chronic obstructive pulmonary disease (COPD).
    Salik Y, Ozalevli S, Cimrin AH.
    Arch Gerontol Geriatr; 2007 Sep 05; 45(3):273-80. PubMed ID: 17343931
    [Abstract] [Full Text] [Related]

  • 32. Emerging concepts in outcome assessment for COPD clinical trials.
    Patel SA, Sciurba FC.
    Semin Respir Crit Care Med; 2005 Apr 05; 26(2):253-62. PubMed ID: 16088442
    [Abstract] [Full Text] [Related]

  • 33. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT.
    Chron Respir Dis; 2009 Apr 05; 6(2):75-80. PubMed ID: 19411567
    [Abstract] [Full Text] [Related]

  • 34. [Fenspiride in patients with acute bronchitis].
    Płusa T, Ochwat A.
    Pol Merkur Lekarski; 2005 Jul 05; 19(109):32-6. PubMed ID: 16194023
    [Abstract] [Full Text] [Related]

  • 35. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar 05; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D.
    Thorax; 2009 Mar 05; 64(3):216-23. PubMed ID: 19052054
    [Abstract] [Full Text] [Related]

  • 37. [Chronic obstructive pulmonary disease].
    Holzgrabe U, Muth M.
    Med Monatsschr Pharm; 2007 May 05; 30(5):168-76; quiz 177-8. PubMed ID: 17526393
    [Abstract] [Full Text] [Related]

  • 38. Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial.
    Sansores R, Ramírez-Vanegas A, Reddy C, Mejía-Alfaro R.
    Arch Med Res; 2003 May 05; 34(4):292-7. PubMed ID: 12957526
    [Abstract] [Full Text] [Related]

  • 39. [May a COPD patient benefit from rehabilitation associated with pharmacological treatment?].
    Kozielski J.
    Pneumonol Alergol Pol; 2012 May 05; 80(5):463-6. PubMed ID: 22926908
    [Abstract] [Full Text] [Related]

  • 40. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN, Broeders ME, Tuut MK, Grol MH.
    Ned Tijdschr Geneeskd; 2008 Jun 28; 152(26):1465-8. PubMed ID: 18666664
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.